Professor Yusuf Kaplan, formerly of the Izmir TIS, and Professor Gideon Koren from the Adelson Faculty of Medicine, Ariel University, Israel and the Motherisk Israel […]
Welcome
ENTIS is a global collaborative network of Teratology Information Services. Member organisations consist of medical doctors, pharmacists, genetic counsellors and scientists all working together with the primary aim of preventing birth defects and developmental disorders which arise as a consequence of maternal or paternal perinatal exposures.
ENTIS member organisations work in three core areas:
ENTIS collaborates with researchers from a range of academic, industry and patient representative organisations. If you are interested in working with ENTIS or in joining our network, please contact us.
Alternatively, click here to learn more about ENTIS.
Latest Teratology Studies
Long-term survival of children born with congenital anomalies
A collaboration of researchers from Newcastle University, the University of London and the University of Ferrara have conducted a systematic review and meta-analysis investigating the […]
Small increased risk of birth defects following first trimester hydroxychloroquine use
A collaborative of researchers from Harvard University’s Medical School and School of Public Health have published a propensity score matched analysis of US Medicaid data which has […]
Meta-analysis of pregnancy outcomes following thiopurine exposure
Researchers from the Department of Pharmacy, Beijing Friendship Hospital, Beijing have published a meta-analysis of pregnancy outcomes following maternal thiopurine use by female patients with […]
Demonstration of immortal time bias in pregnancy pharmacovigilance studies
Researchers from the University of Milano-Bicocca, Italy, have published a useful study which demonstrates the impact of immortal time bias in studies investigating drug safety […]
Review of the fetal safety of medications used in treating infertility
A collaborative review has been published by researchers from Terafar Izmir TIS and Motherisk Isreal discussing the fetal safety of medications used in treating infertility. […]
Letter to the Editor: Safety of proton pump inhibitors during pregnancy
ENTIS colleagues from the Teratology Information, Training and Research Center, Terafar at Izmir Katip Celebi University in Turkey have written a letter to the editor […]
Study comparing buprenorphine and methadone in the management of maternal opioid use disorder
Researchers from the Renaissance School of Medicine at Stony Brook University (New York, USA) have conducted a retrospective analysis of pregnancy outcomes among women with […]